ZAP Surgical Systems has obtained a no objection certificate (NOC) from the Atomic Energy Regulatory Board (AERB) in India for its ZAP-X Gyroscopic Radiosurgery platform.

The approval of the radiosurgery (SRS) platform will expand access to completely non-invasive treatment of brain tumours in the country.

ZAP Surgical India country head Saloni Singh said: “At ZAP, our mission is to expand world-class SRS access to the millions of potential patients who currently lack access throughout the world.

“By reducing the costs and complexities of prior delivery technologies, ZAP-X is enabling broader adoption of such technology and is primed to make a significant impact on patient care in India.”

Claimed to be the latest advance in stereotactic radiosurgery, the ZAP-X system eliminates costs linked with continued source decay, recurring replacement, regulatory licensing and source security.

It also helps avoid the need for live radioactive isotopes.

ZAP Surgical designed the ZAP-X as a vault-free SRS concept to eliminate the use of high-cost radiation-proof treatment bunkers.

The company has opened an office in Gurugram, Haryana, to support the marketing and commercialisation of the new radiosurgery system in the country.

ZAP Surgical IMEA regional business director Ahmed Salem said: “By introducing leading-edge innovations such as self-shielding and a modern linear accelerator, ZAP-X has removed many of the financial and logistical constraints that previously prohibited centres from acquiring SRS technology.

“Where state-of-the-art SRS has historically been concentrated primarily amongst the most well-funded, urban academic hospitals, ZAP-X now makes SRS also feasible in suburban and rural settings – thus bringing potentially life-saving care to previously underserved populations.